RHHBY:OTCMKTS
Roche Holdings AG Basel ADR Common Stock
$51.88
arrow_downward
-0.71%(-0.37) 1D
$51.88
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 30, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RHHBY...
Open
$52.60
High
$52.66
Low
$51.81
Mkt. cap
339.14B
Avg. vol.
2.07M
Volume
1.25M
P/E ratio
22.58
52-wk high
$60.85
52-wk low
$40.07
EPS
$2.30
Beta
0.45
Shares outstanding
5.62B
No. of employees
113K
Open
$52.60
High
$52.66
Low
$51.81
Mkt. cap
339.14B
Avg. vol.
2.07M
Volume
1.25M
P/E ratio
22.58
52-wk high
$60.85
52-wk low
$40.07
EPS
$2.30
Beta
0.45
Shares outstanding
5.62B
No. of employees
113K
News stories
From web sources and news partners
AD HOC NEWS
·
8 minutes ago
Roche acquired Poseida Therapeutics as Poseida Therapeutics stock delisted
Stock Titan
·
4 hours ago
Roche's eye drug showed vision gains or stable sight in three retinal diseases
Stock Titan
·
5 hours ago
A breast cancer treatment in testing lowered risk of worsening or death by 62% for patients with a tumor mutation.
Seeking Alpha
·
15 hours ago
Roche multiple sclerosis pill gets FDA priority review (RHHBY)
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holdings AG Basel ADR Common Stock
CEOThomas Schinecker
Employees113K
FoundedOct 1, 1896
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websiteroche.com